Woodline Partners LP Has $8.41 Million Holdings in Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Woodline Partners LP lowered its position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 26.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 415,120 shares of the company's stock after selling 153,011 shares during the quarter. Woodline Partners LP owned approximately 0.66% of Guardian Pharmacy Services worth $8,410,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Brown Advisory Inc. bought a new position in Guardian Pharmacy Services in the 4th quarter worth approximately $32,294,000. J. Goldman & Co LP raised its position in Guardian Pharmacy Services by 1.5% in the 4th quarter. J. Goldman & Co LP now owns 762,347 shares of the company's stock worth $15,445,000 after purchasing an additional 11,263 shares during the last quarter. Nuveen Asset Management LLC raised its position in Guardian Pharmacy Services by 2.9% in the 4th quarter. Nuveen Asset Management LLC now owns 547,140 shares of the company's stock worth $11,085,000 after purchasing an additional 15,550 shares during the last quarter. Franklin Resources Inc. raised its position in Guardian Pharmacy Services by 2.6% in the 4th quarter. Franklin Resources Inc. now owns 513,029 shares of the company's stock worth $10,394,000 after purchasing an additional 13,029 shares during the last quarter. Finally, New York State Common Retirement Fund raised its position in Guardian Pharmacy Services by 17.9% in the 4th quarter. New York State Common Retirement Fund now owns 278,548 shares of the company's stock worth $5,643,000 after purchasing an additional 42,368 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Truist Financial reissued a "buy" rating and issued a $28.00 price target (up previously from $25.00) on shares of Guardian Pharmacy Services in a report on Monday, May 19th. Wall Street Zen lowered shares of Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a report on Saturday. Finally, Raymond James set a $28.00 price target on shares of Guardian Pharmacy Services and gave the company an "outperform" rating in a report on Wednesday, May 14th.

Guardian Pharmacy Services Price Performance

Shares of GRDN stock traded down $0.36 on Wednesday, hitting $21.77. The stock had a trading volume of 76,201 shares, compared to its average volume of 165,747. Guardian Pharmacy Services, Inc. has a twelve month low of $14.16 and a twelve month high of $26.91. The company has a fifty day moving average price of $23.14 and a two-hundred day moving average price of $22.00.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $0.21 earnings per share for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The company had revenue of $329.31 million for the quarter, compared to analysts' expectations of $321.21 million. On average, equities research analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current year.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.